Dyslipidaemia and Pulmonary tuberculosis

Summary:

Pulmonary tuberculosis is found among people with Dyslipidaemia, especially for people who are male, 60+ old.

The study analyzes which people have Pulmonary tuberculosis with Dyslipidaemia. It is created by eHealthMe based on reports of 13 people who have Dyslipidaemia from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Dyslipidaemia?

Dyslipidaemia (abnormal amount of lipids) is found to be associated with 842 drugs and 711 conditions by eHealthMe. Check the latest studies of Dyslipidaemia.

What is Pulmonary tuberculosis?

Pulmonary tuberculosis (lungs tuberculosis) is found to be associated with 340 drugs and 1,024 conditions by eHealthMe. Check the latest studies of Pulmonary tuberculosis.

On Jul, 12, 2026

13 people who have Dyslipidaemia and Pulmonary Tuberculosis are studied.

Would you have Pulmonary tuberculosis when you have Dyslipidaemia?

Gender of people who have Dyslipidaemia and experienced Pulmonary Tuberculosis *:

female: 38.46 %
male: 61.54 %

Age of people who have Dyslipidaemia and experienced Pulmonary Tuberculosis *:

Common co-existing conditions for these people *:

High Blood Pressure: 8 people, 61.54%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 30.77%
Type 2 Diabetes: 4 people, 30.77%
Insomnia (sleeplessness): 3 people, 23.08%
Constipation: 2 people, 15.38%
Lung Adenocarcinoma Stage Iii (the cancer has spread to nearby tissue or too far away lymph nodes): 2 people, 15.38%
Stable Angina (a constant chest pain): 2 people, 15.38%
Peripheral Arterial Occlusive Disease (reproducible ischemic muscle pain): 1 person, 7.69%
Diabetic Retinopathy (damage to the retina caused by complications of diabetes): 1 person, 7.69%
Asthma: 1 person, 7.69%

Common drugs taken by these people *:

Ethambutol Hydrochloride: 4 people, 30.77%
Isoniazid: 4 people, 30.77%
Amlodipine Besylate: 3 people, 23.08%
Atorvastatin Calcium: 3 people, 23.08%
Humira: 3 people, 23.08%
Pyrazinamide: 3 people, 23.08%
Nexium: 2 people, 15.38%
Januvia: 2 people, 15.38%
Livalo: 2 people, 15.38%
Keytruda: 2 people, 15.38%

Common symptoms for these people *:

Computerised Tomogram Thorax Abnormal: 4 people, 30.77%
Angiotensin Converting Enzyme Increased: 4 people, 30.77%
Blood Creatine Increased: 4 people, 30.77%
Lysozyme Increased: 4 people, 30.77%
Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 4 people, 30.77%
Blood Creatinine Increased: 4 people, 30.77%
Interstitial Nephritis (inflammation of the kidney): 4 people, 30.77%
Blood Urine Present: 4 people, 30.77%
Liver Disorder (liver diseases): 3 people, 23.08%
Sarcoidosis (an inflammatory disease that affects multiple organs in the body, but mostly the lungs and lymph glands): 3 people, 23.08%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Pulmonary tuberculosis?

- Check whether Pulmonary tuberculosis is associated with a drug or a condition

Related studies:

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Pulmonary tuberculosis and Dyslipidaemia, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.